Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Aura Biosciences Inc AURA

Healthcare Biotechnology
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AURA)

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire November 24, 2025

NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

GlobeNewswire November 20, 2025

Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

GlobeNewswire November 13, 2025

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire September 3, 2025

Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights

GlobeNewswire August 13, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

GlobeNewswire May 15, 2025

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire May 15, 2025

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

GlobeNewswire May 15, 2025

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire May 1, 2025
View More News ››

Opinion & Analysis (NDAQ:AURA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AURA)

Aura Biosciences, Inc. (NASDAQ:AURA) &#8211; A Promising Pre

http://beyondspx.com/2024/07/31/aura-biosciences-inc-nasdaqaura-a-promising-precision-immunotherapy-player-poised-for-growth/
MikeTester - August 2, 2024
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral ...
View More »